Abn-Oncology is a translational cancer research resource funded by the National Health and Medical Research Council (NHMRC) Enabling Grant scheme. ABN-Oncology is not itself a Biobank, but rather a network of Biobanks interlinked with view to:
- To supply appropriately collected and ethically consented human tissue, linked to key pathology and outcome data, to the Australian research community including multi-site research projects.
- To facilitate the collection of biospecimens for clinical trials and to form close relationships with clinical trials groups, and bodies such as the Clinical Oncological Society of Australia (COSA).
- To act as a peak body for biobanking within Australia including provision of advice and assistance to both researchers and biobanks on issues related to biobanking in Australia.
- To expand the network by linking biobanks through the listing of their biospecimens on the ABN Tissue Specimen Locator and linkage through the ABN-Oncology Hub.
To create a state, national and international research resource for clinical, epidemiological and molecular research into cancer. The consortium will provide a conduit for researchers to gain access to ethically consented, high quality clinically-annotated biospecimens and data. It also aims to provide a forum to address technical, legal/ethical, and managerial issues relevant to human biospecimen repositories within Australia and New Zealand.